New business is being written on visibly better terms than the company's own recent norm, and the mix shift has just beg
The model's full reasoning — Q3 2023 call → NOWe need answer YES or NO. Need analyze transcript. Question asks: Does management indicate economic terms of newest business have stepped up meaningfully above company's own recent norm, and improvement only begun to flow into reported results because most business in reported numbers still written at older less favorable terms? Need use only transcript. Need identify if management says new business terms improved vs own recent past and reported results still reflect old terms. Transcript: Quanterix Q3 2023. They discuss transformation, gross margins improving, new assays, P-tau217 agreement with J&J, etc. Need see if management indicates pricing/terms of new deals improved and only begun to flow. They mention "we signed a new agreement with Johnson & Johnson Innovative Medicines and launched the Lucent AD P-tau217 blood based biomarker test..." No economic terms disclosed. They say "Quanterix expects majority of the economics to come from our LDT and our kit sales..." Not specific. Gross margin improvement: non-GAAP gross margin 48.6% vs 34.9% prior year. They increased guidance. But is that due to new business terms? They say "corporate transformation has enabled us to reduce inventory losses and drive efficiencies in our processes and this is evident in our gross margin performance." That's cost/efficiency, not pricing. They mention "new assay deployments" will be gross margin accretive. But not necessarily terms improved vs own norm? They say "we expect those new product lines... will be positive for the business." Not actual achieved? Also "assays rolling off new scalable production platform in January." "In 2024, we're going to talk a lot about increasing innovation rate." No mention of higher prices. Question specifically about "economic terms of company's newest business — prices, rates, fees, spreads, contract sizes, durations, or profitability at which its most recent deals, orders, contracts, renewals, or transactions are being struck" have stepped up meaningfully above company's own recent norm, and improvement only begun to flow into reported results because most business in reported numbers still written at older terms. Need see if management says new contracts are at better terms. They don't discuss pricing. They discuss gross margin improvement due to manufacturing efficiencies, not pricing. They discuss new assay launches but not terms.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| CTO | CTO Realty Growth, Inc. | Q2 2023 | 2023-07-28 | B |
| CARS | Cars.com Inc. | Q1 2023 | 2023-05-06 | B |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| CRBG | Corebridge Financial, Inc. | Q4 2022 | 2023-02-22 | B |
| FLR | Fluor Corporation | Q2 2022 | 2022-08-05 | D |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| BRKL | Brookline Bancorp, Inc. | Q2 2022 | 2022-07-30 | B+ |
| INVH | Invitation Homes Inc. | Q2 2022 | 2022-07-28 | B+ |
| MTB | M&T Bank Corporation | Q2 2022 | 2022-07-20 | B+ |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| GNK | Genco Shipping & Trading Limited | Q2 2021 | 2021-08-07 | A |
| ESS | Essex Property Trust, Inc. | Q2 2018 | 2018-08-03 | B+ |
| ALLY | Ally Financial Inc. | Q1 2018 | 2018-04-26 | B+ |
CRL · Q2 2022 → YESThe question is about whether management indicates that the economic terms of the company's newest business have stepped up meaningfully above the company's own recent norm, and that this improvement ...YES Management's comments on Safety Assessment pricing and backlog directly address both required elements: they describe current bookings and backlog at "escalating prices" and "meaningful price increases" that are already achieved on real transactions (not targets or future expectations), while noting that the reported Q2 results are still dominated by older 2022 terms and that the stronger pricing is accelerating into H2 and 2023 bookings.
ESS · Q2 2018 → YESThe question is about whether management indicates that the economic terms of the company's newest business have stepped up meaningfully above the company's own recent norm, and that this improvement ...YES Management describes the loss-to-lease metric rising to 3.
CTO · Q2 2023 → YESThe question is about whether management indicates that the economic terms of the company's newest business have stepped up meaningfully above the company's own recent norm, and that this improvement ...